WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'7601 Infant (under 12 months) mortality rate: 782
GDP / capita (US$): 5'8631 Child (under 5 years) mortality rate: 1242

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 173'615  168'834  164'193  159'708  155'381  122'877  95'617  73'698 
Births 7'173  7'028  6'876  6'718  6'557  5'281  4'220  3'441 
Surviving infants 6'635  6'483  6'325  6'161  5'996  4'691  3'686  2'998 
Pop. less than 5 years 30'546  29'697  28'849  28'006  27'222  21'084  16'809  13'373 
Pop. less than 15 years 77'009  74'742  72'500  70'307  68'299  53'456  42'909  32'411 
Female 15-49 years 39'171  38'161  37'198  36'277  35'342  28'084  21'183  16'567 

Number of reported case

(Click for retrospective incidence data for Nigeria)
Diphtheria 3'995  1'768  165 
Japanese encephalitis
Measles 52'852  6'447  18'843  8'491  1'272  212'183  115'682  162'106 
Mumps
Pertussis 8'530  11'628  11'281  38'910  42'929  48'996 
Polio* 57  130  95  48  541  638  1'873  816 
Rubella 88  239  3'691  450  234 
Rubella (CRS)
Tetanus (neonatal) 468  110  82  176  90  1'643  1'060 
Tetanus (total) 556  112  114  199  1'643  2'703  3'095 
Yellow fever 387  4'075 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nigeria)
Vaccine year result method % card seen                                                
BCG 2010  62  MICS   24  69  87  60  66  67  34  80 
DTP1          72  67  68  84  82  48 
DTP3          65  57  61  74  71  38  56 
HepB_BD          12  12  80 
HepB3 2010  36  MICS   24  65  84  57  66  65 
Hib3          55  62 
JapEnc         
MCV          73  78  93  85  81  30  48 
MCV2         
PCV1         
PCV3         
Pol3 2010  49  MICS   24  67  77  74  69  63  38  55 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  51  MICS   24  39  56  44  39  42  56 
PAB         
VAD1          12 
YFV 2010  50  MICS   24  64  46  72  78  62 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nigeria)
BCG 80  73  46  62  76  44  80 
DTP1 63  32  33  60  73  42  79 
DTP3 58  26  30  54  63  29  56 
HepB3 63  47  31  49  63 
HepB_BD 37  32  31  29  20 
Hib3 46  10 
MCV 59  37  52  56  64  33  54 
MCV2
PAB 60  60  60  69  67  57  32 
PnC3
Pol3 67  52  49  54  66  31  55 
Rota_last
YFV 49  33  50  69 

Number of districts in the country 774  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 56
From 80 to 89% 16
From 50 to 79% 24
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; No
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; 6, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT +1, +6 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011- 2015  2011- 2015  2009 - 2014  2009-2014  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 774  774  774      425   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  Yes  Yes  Yes       

System performance

Total Nº districts in country number 774  774  774  774  774  774  774 
Nº districts with DTP3 coverage >=80% number 554  117  125  309  406  244  84 
% of districts with DTP3 coverage >=80% From 0 to 100% 72  15  16  40  52  32  11 
Nº districts with measles (MCV1) coverage >=95% number 393  192  255  251  304  263   
% of districts with MCV1 coverage >=95% From 0 to 100% 51  25  33  32  39  34   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes    No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes    No  No  Yes  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 55      71  74  90   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.